PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
Breast cancer is the most commonly diagnosed cancer in women. The high incidence of breast cancer, which is continuing to rise, makes treatment a significant challenge. The PI3K–AKT pathway and its downstream targets influence various cellular processes. In recent years, mounting evidence has shown...
Main Authors: | Yeqin Yuan, Huizhi Long, Ziwei Zhou, Yuting Fu, Binyuan Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/1/93 |
Similar Items
-
Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01) -
Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic
by: Aglaia Skolariki, et al.
Published: (2022-04-01) -
Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction
by: Hui Zhang, et al.
Published: (2016-01-01) -
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway
by: Birlipta Pattanayak, et al.
Published: (2022-10-01) -
Pinocembrin Inhibits the Proliferation and Metastasis of Breast Cancer via Suppression of the PI3K/AKT Signaling Pathway
by: Xinbing Zhu, et al.
Published: (2021-07-01)